Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 71.36 | 76.23 | 74.26 | 69.74 |
Total Revenue | 71.36 | 76.23 | 74.26 | 69.74 |
Costof Revenue Total | 54.86 | 62.30 | 60.84 | 57.62 |
Gross Profit | 16.49 | 13.92 | 13.42 | 12.12 |
Selling/ General/ Admin Expenses Total | 3.92 | 3.22 | 2.31 | 2.17 |
Depreciation/ Amortization | 0.29 | 0.20 | 0.21 | 0.14 |
Other Operating Expenses Total | 6.36 | 4.93 | 5.80 | 5.00 |
Total Operating Expense | 65.42 | 70.66 | 69.16 | 64.93 |
Operating Income | 5.93 | 5.56 | 5.10 | 4.81 |
Interest Inc( Exp) Net- Non- Op Total | -4.93 | -6.19 | -8.74 | -12.80 |
Net Income Before Taxes | 5.44 | 4.94 | 4.23 | 3.53 |
Provisionfor Income Taxes | 1.49 | 1.34 | 1.13 | 0.96 |
Net Income After Taxes | 3.95 | 3.61 | 3.10 | 2.58 |
Net Income Before Extra Items | 3.95 | 3.61 | 3.10 | 2.58 |
Net Income | 3.95 | 3.61 | 3.10 | 2.58 |
Income Availableto Com Excl Extra Ord | 3.95 | 3.61 | 3.10 | 2.58 |
Income Availableto Com Incl Extra Ord | 3.95 | 3.61 | 3.10 | 2.58 |
Diluted Net Income | 3.95 | 3.61 | 3.10 | 2.58 |
Diluted Weighted Average Shares | 1.00 | 0.64 | 0.32 | 0.32 |
Diluted EPS Excluding Extra Ord Items | 3.95 | 5.61 | 9.54 | 7.93 |
Diluted Normalized EPS | 3.95 | 5.61 | 9.54 | 7.93 |
Total Adjustmentsto Net Income | - | 0.00 | 0.00 | - |
DPS- Common Stock Primary Issue | - | 0.10 | - | - |
Medico Intercontinental Dividend Medico Intercontinental Bonus Medico Intercontinental News Medico Intercontinental AGM Medico Intercontinental Rights Medico Intercontinental Splits Medico Intercontinental Board Meetings Medico Intercontinental Key Metrics Medico Intercontinental Shareholdings Medico Intercontinental Balance Sheet Medico Intercontinental Cashflow Medico Intercontinental Q1 Results Medico Intercontinental Q2 Results Medico Intercontinental Q3 Results Medico Intercontinental Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks